Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17931 (
galectin-3
)
2,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The production of
eosinophil cationic protein
(
ECP
) in IgE-mediated diseases has been associated mainly with eosinophils, although no IgE-dependent
ECP
release has been observed in these cells. Because there is increasing evidence of neutrophil participation in allergic processes, we have examined whether human neutrophils from allergic patients were able to produce
ECP
by an IgE-dependent mechanism. After challenge with specific Ags to which the patients were sensitized,
ECP
release was detected in the culture medium. Furthermore, intracellular protein was detected by flow cytometry, immunofluorescence staining, and Western blotting. Expression at both mRNA and de novo protein synthesis were detected, respectively, by RT-PCR and radiolabeling with (35)S. Ag effect was mimicked by cell treatment with anti-IgE Abs or Abs against FcepsilonRI and
galectin-3
(FcepsilonRI>
galectin-3
), but not against FcepsilonRII. These observations represent a novel view of neutrophils as possible source of
ECP
in IgE-dependent diseases.
...
PMID:Neutrophils as a novel source of eosinophil cationic protein in IgE-mediated processes. 1767 27